NEWARK, Del. — According to Future Market Insights (FMI), the global alpha gal syndrome allergy market is valued at USD 1.3 billion in 2026 and is projected to reach USD 3.7 billion by 2036, expanding at a 11.0% CAGR during the 2026–2036 forecast period. Increasing identification of alpha-gal syndrome cases is strengthening demand for targeted diagnostic testing and coordinated...